319
Participants
Start Date
September 29, 2021
Primary Completion Date
October 3, 2024
Study Completion Date
April 29, 2025
Afrezza
"Pharmaceutical form: powder~Route of administration: inhalation"
Rapid-acting Insulin Analog
"Pharmaceutical form: clear and colorless solution for injection~Route of administration: subcutaneous"
Basal Insulin
"Pharmaceutical form: solution for injection~Route of administration: subcutaneous"
NYU Langone, Hassenfeld Children's Hospital, New York
UBMD Pediatrics Buffalo, Buffalo
Children's Hospital of Philadelphia, Philadelphia
Nemours Children's Hospital, Delaware, Wilmington
Dr. Barry J. Reiner, Baltimore
Johns Hopkins University, Baltimore
Virginia Commonwealth University, Richmond
Emory University, Children's Healthcare of Atlanta, Atlanta
University of Florida, Gainesville
Advent Health Orlando, Orlando
Joe DiMaggio Children's Hospital, Hollywood
University of South Florida, Tampa
AM Diabetes and Endocrinology Center, Bartlett
University of Louisville, Norton Children's Hospital, Louisville
University Hospitals Cleveland Medical Center, Cleveland
Cincinnati Children's Hospital, Cincinnati
Indiana University, Indianapolis
Michigan Pediatric Endocrine and Diabetes Services, Livonia
Iowa Diabetes Research, IDR, West Des Moines
University of Iowa, Iowa City
Medical College of Wisconsin, Milwaukee
University of Minnesota, Minneapolis
Children's Mercy Hospital, Kansas City
Oklahoma Children's Hospital, Oklahoma City
UT Southwestern, Dallas
Diabetes & Glandular Disease Clinic, DGD, San Antonio
DHR Health, Edinburg
Rocky Mountain Clinical Research, Idaho Falls
The DOCS, Las Vegas
Children's Hospital Los Angeles, Los Angeles
University of California San Diego, Rady Children's Hospital, San Diego
Children's Hospital of Orange County, Orange
University of California San Francisco, San Francisco
Stanford University, Palo Alto
Sutter Institute for Medical Research (formerly Center of Excellence in Diabetes and Endocrinology), Sacramento
Seattle Children's, Seattle
Yale New Haven Hospital, New Haven
Joslin Diabetes Center, Boston
Atlantic Health, Morristown
Lead Sponsor
Collaborators (1)
Jaeb Center for Health Research
OTHER
Mannkind Corporation
INDUSTRY